ICD-10: H11.023

Central pterygium is a condition characterized by the growth of a fleshy tissue on the conjunctiva, which is the clear membrane covering the white part of the eye. When this condition occurs bilaterally, it affects both eyes, leading to potential visual disturbances and discomfort. Below is a detailed clinical description and relevant information regarding the ICD-10 code H11.023, which specifically denotes bilateral central pterygium of the eye.

Clinical Description of Central Pterygium

Definition

A pterygium is a benign growth that typically arises from the conjunctiva and extends onto the cornea. It is often triangular in shape and can vary in size. Central pterygium specifically refers to the location of the growth, which occurs centrally on the cornea.

Symptoms

Patients with bilateral central pterygium may experience a range of symptoms, including:
- Redness and irritation: The affected eyes may appear red and feel irritated.
- Visual disturbances: As the pterygium grows, it can distort vision by altering the shape of the cornea.
- Dryness and discomfort: Patients may report a sensation of dryness or a foreign body feeling in the eyes.
- Cosmetic concerns: The appearance of the pterygium can be distressing for some individuals.

Etiology

The exact cause of pterygium is not fully understood, but several factors are believed to contribute to its development:
- UV exposure: Prolonged exposure to ultraviolet (UV) light is a significant risk factor, particularly in individuals who spend a lot of time outdoors.
- Environmental factors: Dust, wind, and other environmental irritants may also play a role.
- Genetic predisposition: A family history of pterygium may increase the likelihood of developing the condition.

Diagnosis

Diagnosis of bilateral central pterygium typically involves:
- Clinical examination: An eye care professional will perform a thorough examination of the eyes, often using a slit lamp to assess the extent of the pterygium.
- Patient history: A detailed history regarding symptoms, exposure to risk factors, and any previous eye conditions will be taken into account.

Treatment

Treatment options for bilateral central pterygium may include:
- Observation: If the pterygium is small and not causing significant symptoms, monitoring may be sufficient.
- Topical medications: Anti-inflammatory eye drops may help alleviate symptoms.
- Surgical intervention: In cases where the pterygium causes significant visual impairment or discomfort, surgical removal may be recommended. This procedure often involves excising the pterygium and may include grafting to prevent recurrence.

ICD-10 Code H11.023

Code Details

• ICD-10 Code: H11.023
• Description: Central pterygium of eye, bilateral
• Classification: This code falls under the category of "Other disorders of the conjunctiva" in the ICD-10 classification system.

Importance of Accurate Coding

Accurate coding is essential for proper diagnosis, treatment planning, and insurance reimbursement. The use of the specific code H11.023 ensures that healthcare providers can effectively communicate the nature of the condition and its bilateral presentation.

Conclusion

Bilateral central pterygium is a common ocular condition that can lead to discomfort and visual impairment. Understanding its clinical features, potential causes, and treatment options is crucial for effective management. The ICD-10 code H11.023 serves as a vital tool for healthcare professionals in documenting and treating this condition. If you suspect you have symptoms of pterygium, it is advisable to consult an eye care specialist for a comprehensive evaluation and appropriate management.

Central pterygium, particularly when bilateral, is a condition characterized by the growth of a fleshy tissue on the conjunctiva that can extend onto the cornea. This condition is often associated with prolonged exposure to environmental factors such as UV light, wind, and dust. Below is a detailed overview of the clinical presentation, signs, symptoms, and patient characteristics associated with ICD-10 code H11.023, which specifically refers to bilateral central pterygium of the eye.

Clinical Presentation

Definition

Central pterygium is defined as a triangular-shaped growth of fibrovascular tissue that originates from the conjunctiva and invades the cornea. When bilateral, it affects both eyes, which can lead to more pronounced symptoms and visual disturbances.

Patient Characteristics

• Demographics: Central pterygium is more common in individuals who are frequently exposed to sunlight, such as outdoor workers, farmers, and those living in sunny climates. It typically occurs in adults, particularly those aged 20 to 50 years.
• Gender: There is a slight male predominance in the incidence of pterygium, although it can affect both genders equally.

Signs and Symptoms

Common Symptoms

1. Visual Disturbances: Patients may experience blurred vision if the pterygium encroaches on the visual axis of the cornea.
2. Irritation and Discomfort: Many patients report a sensation of foreign body presence, dryness, or irritation in the affected eyes.
3. Redness: The conjunctival tissue may appear red or inflamed due to the vascular nature of the pterygium.
4. Tearing: Increased tear production can occur as a response to irritation.

Clinical Signs

1. Appearance: The pterygium typically presents as a triangular, fleshy growth that starts from the nasal or temporal conjunctiva and extends towards the center of the cornea.
2. Bilateral Involvement: In cases of bilateral pterygium, both eyes will exhibit similar growths, which may vary in size and severity.
3. Corneal Changes: As the pterygium progresses, it may cause astigmatism or other corneal irregularities, which can be assessed through corneal topography.

Diagnosis

Diagnosis is primarily clinical, based on the characteristic appearance of the pterygium during a comprehensive eye examination. Additional tests may include:
- Slit-lamp Examination: To assess the extent of the pterygium and any associated corneal changes.
- Visual Acuity Testing: To determine the impact of the pterygium on vision.

Management

Management options for bilateral central pterygium may include:
- Observation: In asymptomatic cases or when the pterygium is not encroaching on the visual axis.
- Medical Treatment: Topical anti-inflammatory medications may be prescribed to reduce irritation and inflammation.
- Surgical Intervention: If the pterygium causes significant visual impairment or discomfort, surgical excision may be necessary, often followed by conjunctival autografting to minimize recurrence.

Conclusion

Bilateral central pterygium of the eye (ICD-10 code H11.023) presents with a range of symptoms and signs that can significantly impact a patient's quality of life. Understanding the clinical characteristics and management options is crucial for healthcare providers to offer appropriate care and improve patient outcomes. Regular monitoring and protective measures against UV exposure are essential for individuals at risk of developing this condition.

Central pterygium of the eye, particularly when bilateral, is a condition characterized by the growth of a fleshy tissue on the conjunctiva that can extend onto the cornea. The ICD-10 code for this condition is H11.023. Below are alternative names and related terms that may be associated with this diagnosis.

Alternative Names

1. Bilateral Pterygium: This term emphasizes the bilateral nature of the condition, indicating that it affects both eyes.
2. Pterygium Bilaterale: A Latin term that is sometimes used in medical literature to describe bilateral pterygium.
3. Conjunctival Pterygium: This term highlights the origin of the growth from the conjunctiva.
4. Corneal Pterygium: While this term is broader, it can refer to pterygium that affects the cornea, which is relevant in cases where the growth extends onto the corneal surface.

Related Terms

1. Pterygium: A general term for the condition, which can be unilateral or bilateral.
2. Pinguecula: A related condition that involves a yellowish, raised growth on the conjunctiva, often confused with pterygium but typically does not invade the cornea.
3. Conjunctival Growth: A broader term that can encompass various types of growths on the conjunctiva, including pterygium.
4. Ocular Surface Disease: A term that may be used in a broader context to describe conditions affecting the surface of the eye, including pterygium.

Clinical Context

Understanding these alternative names and related terms is essential for accurate diagnosis, treatment planning, and coding in medical records. Clinicians may encounter these terms in various contexts, including patient discussions, medical literature, and billing practices.

In summary, the ICD-10 code H11.023 for bilateral central pterygium can be referred to by several alternative names and related terms, which are important for clear communication in clinical settings.

Central pterygium, classified under ICD-10 code H11.023, refers to a growth of tissue on the conjunctiva that can extend onto the cornea, typically affecting both eyes in this case. The diagnosis of bilateral central pterygium involves several criteria and considerations, which are outlined below.

Clinical Presentation

Symptoms

Patients with central pterygium may present with various symptoms, including:
- Redness: The affected area may appear inflamed or red.
- Irritation: Patients often report a sensation of grittiness or irritation in the eyes.
- Vision Changes: As the pterygium grows, it can affect vision by distorting the cornea or causing astigmatism.
- Cosmetic Concerns: The appearance of the eye may lead to cosmetic dissatisfaction.

Physical Examination

A thorough eye examination is crucial for diagnosing central pterygium. Key aspects include:
- Visual Acuity Testing: Assessing the impact of the pterygium on vision.
- Slit-Lamp Examination: This allows for detailed observation of the conjunctiva and cornea, identifying the presence and extent of the pterygium.
- Assessment of Growth: The size, shape, and location of the pterygium are evaluated, particularly its central position and bilateral occurrence.

Diagnostic Criteria

Medical History

• Exposure History: A history of prolonged exposure to UV light, dust, or wind may be relevant, as these factors are known risk contributors to pterygium development.
• Previous Eye Conditions: Any history of eye injuries or other ocular conditions should be documented.

Imaging and Tests

While imaging is not typically required for diagnosis, in some cases, additional tests may be performed to assess the extent of corneal involvement or to rule out other conditions:
- Corneal Topography: This may be used to evaluate the corneal surface and any induced astigmatism due to the pterygium.
- Ocular Photography: External ocular photography can document the appearance and progression of the pterygium over time.

Differential Diagnosis

It is essential to differentiate central pterygium from other conditions that may present similarly, such as:
- Pinguecula: A yellowish, raised growth on the conjunctiva that does not invade the cornea.
- Conjunctival Neoplasms: Tumors that may mimic the appearance of pterygium but have different implications and management.

Conclusion

The diagnosis of bilateral central pterygium (ICD-10 code H11.023) is primarily clinical, relying on patient history, symptoms, and a comprehensive eye examination. Understanding the criteria for diagnosis helps in managing the condition effectively, including monitoring for progression and determining the need for surgical intervention if vision is significantly affected or for cosmetic reasons. If you have further questions or need additional information, feel free to ask!

Central pterygium, particularly when bilateral, is a common ocular condition characterized by a growth of conjunctival tissue that extends onto the cornea. The ICD-10 code H11.023 specifically refers to this condition affecting both eyes. Treatment approaches for bilateral central pterygium can vary based on the severity of the condition, symptoms, and the impact on vision. Below is a detailed overview of standard treatment options.

Treatment Approaches for Bilateral Central Pterygium

1. Observation and Monitoring

In cases where the pterygium is small and asymptomatic, a conservative approach may be adopted. Regular monitoring is essential to assess any changes in size or symptoms. Patients are advised to protect their eyes from UV exposure and irritants, which can exacerbate the condition.

2. Medical Management

For symptomatic relief, especially if the pterygium causes irritation or redness, the following medical treatments may be employed:

• Topical Lubricants: Artificial tears can help alleviate dryness and discomfort associated with pterygium.
• Anti-inflammatory Medications: Corticosteroid eye drops may be prescribed to reduce inflammation and redness, particularly during flare-ups.

3. Surgical Intervention

Surgery is often indicated for larger pterygia or when they cause significant visual impairment or discomfort. The surgical options include:

• Pterygium Excision: The most common surgical procedure involves the removal of the pterygium. This is typically performed under local anesthesia. The excised area may be covered with a conjunctival graft to minimize recurrence.

• Conjunctival Grafting: This technique involves taking a graft from the healthy conjunctiva (the membrane covering the white part of the eye) to cover the area where the pterygium was removed. This method significantly reduces the risk of recurrence compared to excision alone.

• Mitomycin C Application: In some cases, mitomycin C, an antineoplastic agent, may be applied to the surgical site to further decrease the likelihood of recurrence. This is particularly useful in patients with a history of recurrent pterygium.

4. Postoperative Care

Post-surgery, patients typically require follow-up visits to monitor healing and manage any complications. Common postoperative care includes:

• Use of Anti-inflammatory Drops: To control inflammation and promote healing.
• Avoiding Sun Exposure: Patients are advised to wear UV-blocking sunglasses to protect the eyes from sunlight, which can contribute to recurrence.

5. Lifestyle Modifications

Patients are encouraged to adopt certain lifestyle changes to prevent the progression of pterygium:

• UV Protection: Wearing sunglasses with UV protection can help prevent further growth of pterygium.
• Environmental Modifications: Reducing exposure to wind, dust, and other irritants can also be beneficial.

Conclusion

Bilateral central pterygium can significantly impact a patient's quality of life, particularly if it leads to discomfort or visual impairment. Treatment options range from conservative management to surgical intervention, depending on the severity of the condition. Regular follow-up and lifestyle modifications play a crucial role in managing this condition effectively. If you or someone you know is experiencing symptoms of pterygium, consulting an ophthalmologist for a tailored treatment plan is advisable.